When glucose is added to cells of the yeast Succharomyces cerevisiae grown on non-fermentable carbon sources, a cAMP signal is induced which triggers a protein phosphorylation cascade. Addition of glucose or fructose to cells of a phosphoglucose isomerase mutant also induced the cAMP signal indicating that metabolization of the sugar beyond the sugar phosphate step is not necessary. Glucose 6-phosphate might stimulate the triggering reaction since induction with fructose shows a significant delay. Experiments with double and triple mutants in hexokinase 1, hexokinase 2 or glucokinase indicated that the presence of one of the three kinases was both necessary and enough for induction of the cAMP signal by glucose and the presence of one of the two hexokinases necessary and enough for induction by fructose. The product of the kinase reaction itself however does not appear to be the trigger of the reaction: when the increase in the level of glucose 6-phosphate and fructose 6-phosphate was measured as a function of time after addition of different glucose concentrations, no correlation was observed with the increase in the cAMP level. From the dependence of the cAMP increase on the external concentration of glucose, a rough estimate was obtained of the K , of the triggering reaction: about 25 mM. This value clearly fits with the K , of the low-affinity glucose carrier (about 20 mM) and differs by at least an order of magnitude from the K , values of the high-affinity glucose carrier and the three kinases. The present results situate the primary triggering reaction at the level of transport-associated phosphorylation. The main (= low-affinity) glucose carrier appears to be the receptor while association of the corresponding kinase is needed for induction of the signal. Since it is known that the presence of the kinases influences the characteristics of sugar transport, no definite conclusion can be given on whether the necessity of the kinases reflects the need for a certain type of transport or the need for phosphorylation of the sugar. The increase in the level of fructose 1,6-bisphosphate, on the other hand, correlated very well with the cAMP increase. However, it clearly lagged behind the cAMP increase, confirming the previously suggested importance of the cAMP signal for the stimulation of glycolytic flux at the level of phosphofructokinase 1. The importance of the cAMP signal for the stimulation of phosphofructokinase 1 also provides an explanation for the transient overshoot in the levels of glucose 6-phosphate and fructose 6-phosphate which are observed after addition of glucose to derepressed yeast cells. Addition of glucose to glucoserepressed wild-type cells triggers no or just a very weak cAMP signal, indicating that one of the intermediates in the induction sequence must be glucose repressible. This conclusion was confirmed by experiments with wild-type cells grown on either galactose or maltose (which have less glucose repression) and with cells of the hxk2 mutant which is deficient in glucose repression...
We developed reverse transcriptase (RT) PCR assays for the detection of mRNA from three spliced genes of human herpesvirus 6 (HHV-6), the immediate-early genes U16/U17 and U89/U90 and the late gene U60/U66. Sequence analysis determined the splicing sites of these genes. The new assays may be instrumental in investigating the association between HHV-6 and disease.Human herpesvirus 6 (HHV-6) is the causative agent of exanthema subitum (10). High HHV-6 viral loads have been demonstrated in the settings of allograft rejection, immunodeficiencies, malignancies, and multiple sclerosis, although an etiological correlation is still uncertain (1). This is primarily due to the lack of sensitive diagnostic tools specific for active infection. PCR detection of viral DNA in plasma has been proposed as a marker of active infection, but its sensitivity is low (9). The aim of the present work was to develop HHV-6 reverse transcriptase (RT)-PCR assays, since the expression of viral mRNA constitutes an unambiguous marker of active infection. To discriminate mRNA from genomic DNA, we focused on the detection of spliced gene expression; here we report on RT-PCR assays for the immediate-early genes U16/ U17 and U89/U90 and the late gene U60/U66, as well as on the splicing patterns of these genes for both HHV-6A and HHV-6B.HHV-6A(GS) strain was propagated in the human T-cell line HSB-2; HHV-6B(PL1) strain was propagated in activated peripheral blood mononuclear cells (PBMC). mRNA was extracted using oligo(dT) 25 -coated magnetic beads (Dynabeads mRNA direct kit; Dynal, Oslo, Norway), and total RNA was extracted using the Qiagen RNeasy minikit (Qiagen, Hilden, Germany). Primers (Table 1) were designed based on the HHV-6(U1102) sequence (4).Poly(A) ϩ RNA was treated with the Access RT-PCR kit (Promega, Madison, Wis.). Except for primers C1bis and C2bis, initial denaturation (94°C for 2 min) was followed by 35 amplification cycles (94°C for 1 min, 50°C for 1 min, and 72°C for 2 min) and by final elongation (72°C for 10 min). For primers C1bis and C2bis, initial denaturation (95°C for 15 min) was followed by 40 amplification cycles (95°C for 20 s, 50°C for 45 s, and 72°C for 30 s) and by final elongation (72°C for 2 min).Total RNA samples were treated (35°C for 15 min) with RNase-free DNase (Ambion, Austin, Tex.) and then subjected to reverse transcription (36°C for 90 min) using Moloney murine leukemia virus RT (Promega). One-tenth of the RT reaction mixture was added to 50 pmol of each primer, 100 M each deoxynucleoside triphosphate, 2.5 mM MgCl 2 , 1ϫ Perkin-Elmer buffer II, and 1.25 U of Taq polymerase (Applied Biosystems, Foster City, Calif). Initial denaturation (95°C for 15 min) was followed by 40 amplification cycles (95°C for 20 s, 60°C [50°C for primers C1bis and C2bis] for 45 s and 72°C for 30 s) and by final elongation (72°C for 2 min).For sequencing, amplimers were purified using the Qiaquick spin extraction kit (Qiagen), amplified, and sequenced with the primers mentioned above (Table 1; Fig. 1). The nucleotide positions of...
Addition of glucose to Saccharomyces cerevisiae cells grown on a nonfermentable carbon source triggers a cyclic AMP (cAMP) signal, which induces a protein phosphorylation cascade. In a yeast strain lacking functional RAS1 and RAS2 genes and containing a bcy mutation to suppress the lethality of RAS deficiency, the cAMP signal was absent. Addition of dinitrophenol, which stimulates in vivo cAMP synthesis by lowering intracellular pH, also did not enhance the cAMP level. A bcy control strain, with functional RAS genes present, showed cAMP responses similar to those of a wild-type strain. In disruption mutants containing either a functional RAS1 gene or a functional RAS2 gene, the cAMP signal was not significantly different from the one in wild-type cells, indicating that RAS function cannot be a limiting factor for cAMP synthesis during induction of the signal. Compared with wild-type cells, the cAMP signal decreased in intensity with increasing temperature in a ras2 disruption mutant. When the mutant RAS2Val-19, which carries the equivalent of the human H-rasVal-12 oncogene, was grown under conditions in which RAS1 expression is repressed, the cAMP signal was absent. The oncogene product is known to be deficient in GTPase activity. However, the amino acid change at position 19 (or 12 in the corresponding human oncogene product) might also have other effects, such as abolishing receptor interaction. Such an additional effect probably provides a better explanation for the lack of signal transmission than the impaired GTPase activity. When the RAS2Val-19 mutant was grown under conditions in which RAS1 is expressed, the cAMP signal was present but significantly delayed compared with the signal in wild-type cells. This indicates that oncogenic RAS proteins inhibit normal functioning of wild-type RAS proteins in vivo and also that in spite of the presence of the RAS2(Val-19) oncogene, adenyl cyclase is not maximally stimulated in vivo. Expression of only the RAS(Val-19) gene product also prevented most of the stimulation of cAMP synthesis by dinitrophenol, indicating that lowered intracellular pH does not act directly on adenyl cyclase but on a step earlier in the activation pathway of the enzyme. The results obtained with the control bcy strain, the RAS2(Val-19) strain under conditions in which RAS1 is expressed, and with dinitrophenol show that the inability of the oncogene product to mediate the cAMP signal is not due to feedback inhibition by the high protein kinase activity in strains containing the RAS2(Val-19) oncogene. Hence, the present results show that the RAS protein in S. cerevisiae are involved in the transmission of the glucose-induced cAMP signal and that the oncogenic RAS protein is unable to act as a signal transducer. The RAS protein in S. cerevisiae apparently act similarly to the Gs proteins of mammalian adenyl cyclase, but instead of being involved in hormone signal transmission, they function in a nutrient-induced signal transmission pathway.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.